NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
Roche »17/12/2009 [Industry news]
Roche lends helping hand to MOH to support organ transplant programs

Roche Pharmaceuticals is teaming up with the Ministry of Health (MOH) to launch the China Organ Transplant Development Program, according to Beijing Youth Daily December 16.

 
Roche Pharmaceuticals is teaming up with the Ministry of Health (MOH) to launch the China Organ Transplant Development Program, according to Beijing Youth Daily December 16. The first phase of the program will span two years. The program will focus on improving the organ transplant registration system, boosting academic exchanges at home and abroad, expanding transplant recipient education programs, and establishing a system to manage patients with renal failure who are awaiting transplants. Products marketed by Roche in China used in the transplant community include CellCept (mycophenolate mofetil), Valcyte (valganciclovir), and Zenapax (daclizumab). As of 2008, a total of 86,800 organ transplants have been performed in China - an annual figure second only to the US.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.